How many insider declarations has Davidow Robert L filed?

Davidow Robert L has filed 1 public insider declaration with SEC (Form 4).

What is Davidow Robert L's role?

Davidow Robert L's reported role is not specified by the regulator across the filings.

Which companies does Davidow Robert L report trades for?

Davidow Robert L reports trades for Avenue Therapeutics, INC..

What is Davidow Robert L's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 34k€.

← Executives ★ Sign in to follow

DR

Davidow Robert L

·SEC (Form 4)

Avenue Therapeutics, INC.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€34,331

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Davidow Robert L. Insider active across 1 company, notably Avenue Therapeutics, INC.. Aggregated, 1 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €34k. Activity tracked since 11 December 2023. The latest transaction was disclosed on 11 December 2023 (Cession). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Davidow Robert L

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Avenue Therapeutics, INC. (US)

申报1 总计

▼

Davidow Robert L

高管2023年12月11日Avenue Therapeutics, INC.

US$36,96010SEC ↗

264,000 股@ US$0.14100.0% 占其流量Common StockSEC:0001553350-23-000471:0

1 条申报中的 1 条

InsidersTradesSigma

← Executives ★ Sign in to follow

DR

Davidow Robert L

·SEC (Form 4)

Avenue Therapeutics, INC.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€34,331

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Davidow Robert L. Insider active across 1 company, notably Avenue Therapeutics, INC.. Aggregated, 1 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €34k. Activity tracked since 11 December 2023. The latest transaction was disclosed on 11 December 2023 (Cession). Regulator: SEC (Form 4). The full history is free.